latest news releases from the newsroom
T-3 Energy Services, Inc.
T-3 Energy Services, Inc. Announces Disposition of 4.5 Million Shares by First Reserve Fund VIII, L.P.
HOUSTON, Nov. 30, 2006 (PRIME NEWSWIRE) -- T-3 Energy Services, Inc. ("T-3") (Nasdaq:TTES) today announced that First Reserve Fund VIII, L.P. ("First Reserve Fund VIII") sold 4,500,000 shares of common stock of T-3 in a series of block trades. First Reserve Fund VIII, which first capitalized T-3 in 2000, is managed by First Reserve Corporation ("First Reserve"), a private equity firm specializing in the energy industry. Prior to the sale, First Reserve beneficially owned approximately 84.8% of T-3's outstanding common stock through First Reserve Fund VIII. Following the sale, First Reserve beneficially owns approximately 44.3% of T-3's common stock.
Delta Air Lines, Inc.
Delta to Offer Customers Only Nonstop Service Between Salt Lake City and Charlotte
SALT LAKE CITY, Nov. 30, 2006 (PRIME NEWSWIRE) -- Customers in the western United States will have another reason to choose Delta this winter as Delta begins the only nonstop service between Salt Lake City and Charlotte, N.C., effective March 1, 2007. The additional flights are part of Delta's expansion of its western hub, offering business travelers convenient flights to important business destinations across the country.
Pomerantz Law Firm Comments on Committee on Capital Markets Regulations
NEW YORK, Nov. 30, 2006 (PRIME NEWSWIRE) -- The last five years have borne witness to the greatest corporate frauds in United States history. Indeed, the most recent breed of scandal -- options backdating -- seems to implicate more and more corporations every week. It seems obvious that these events call out for greater scrutiny and transparency of corporations, in order to assure the integrity of our financial markets. Instead, however, a report issued today by the so-called "Committee on Capital Markets Regulations" seeks to reduce the accountability of corporations, their executives, accountants and others.
Acura Pharmaceuticals Inc.
Acura Pharmaceuticals, Inc. Secures Bridge Funding
PALATINE, Ill., Nov. 30, 2006 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTCBB:ACUR) today announced it has secured gross proceeds of $534,000 and a commitment for additional funding of up to $1.466 million under a term loan agreement (the "November Bridge Loan") with Essex Woodlands Health Ventures V, L.P., Care Capital Investments II, L.P., Care Capital Offshore Investments II, L.P., Galen Partners III, L.P., Galen Partners International III, L.P. and Galen Employee Fund III, L.P. The November Bridge Loan bears an annual interest rate of 10%, is secured by a lien on all assets of the Company and its subsidiary, matures on March 31, 2007 and is senior to all other Company debt. Coincident with the November Bridge Loan, all prior bridge loans to the Company were amended (the "Bridge Loan Amendment") to extend the maturity date to March 31, 2007 and to accept in satisfaction of the interest payments due under all bridge loans, including the November Bridge Loan, a number of shares of Common Stock of the Company based on the average of the closing bid and asked prices of the Common Stock for the five trading days immediately preceding the interest payment date. Including the $534,000 secured today, the Company has a total of $7.278 million in bridge loans outstanding and due on March 31, 2007.